Global  

Humanigen sees first coronavirus patient treated in Phase 3 trial of lenzilumab

Proactive Investors Wednesday, 6 May 2020
Humanigen Inc (OTCQB:HGEN) announced Wednesday that the first coronavirus (COVID-19) patient has been dosed in a Phase 3 trial of its drug lenzilumab. Lenzilumab is a proprietary anti-human granulocyte macrophage-colony stimulating factor (GM-CSF), which the company believes can potentially prevent serious outcomes in hospitalized patients with COVID-19 pneumonia. The now ongoing trial is the first randomized, double-blind, placebo-controlled, multi-center, Phase 3 study of an anti-GM-CSF conducted in the US, the company said. READ: Humanigen wins FDA nod to commence Phase III study of lenzilumab in coronavirus patients "We are working with some of the top centers and clinicians in the US, alongside our contract research organization partner, CTI, to advance lenzilumab through Phase III with the intent to prevent serious and potentially fatal outcomes in high-risk patients who are hospitalized with COVID-19,” Humaigen CEO Cameron Durrant said in a statement. “We are encouraged by our experiences in the compassionate use patients treated with lenzilumab and look forward to working with stakeholders to share these data." Lenzilumab is designed to mitigate what's known as the cytokine storm, an overactive immune response to the coronavirus that can cause inflammation and in the lungs and fluid build-up, which can lead to respiratory issues and be contaminated by secondary bacterial pneumonia. "GM-CSF has been shown to be earlier in the cascade, or ‘upstream', of multiple other cytokines, such as IL-6, IL-1 and TNF-α in cytokine storm,” Durrant added. “Excess GM-CSF production is thought to be the key initial trigger in certain disease states that may lead to significant ‘downstream' consequences, as these and other cytokines become elevated.  “Therefore, the possibility exists that cytokine storm may be prevented or minimized by neutralizing GM-CSF. As the only company working on prevention of cytokine storm through GM-CSF neutralization for nearly three years, we have multiple accepted publications in this field, substantial safety data, including in patients with severe respiratory disease, and have filed extensive IP." CTI Clinical Trial and Consulting Services is a global, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services. It has clinical trial experience across six continents and partners with research sites, patients, and sponsors to fulfil unmet medical needs. Contact Andrew Kessel at [email protected]  Follow him on Twitter @andrew_kessel
0
shares
ShareTweetSavePostSend
 
Video Credit: CBS 5 SF KPIX - Published
News video: CORONAVIRUS: California Preparing To Move Into Phase 2 Of Coronavirus Lockdown Reopening Plan

CORONAVIRUS: California Preparing To Move Into Phase 2 Of Coronavirus Lockdown Reopening Plan 02:27

California Preparing To Move Into Phase 2 Of Coronavirus Lockdown Reopening Plan

You Might Like


Related videos from verified sources

Unlock 1.0: Kalkaji Temple priest urges devotees to wear masks, avoid bringing offerings [Video]

Unlock 1.0: Kalkaji Temple priest urges devotees to wear masks, avoid bringing offerings

The Kalkaji Temple is all set to reopen for devotees from June 08 under the first phase of unlock. The temple will open after 2 months of coronavirus lockdown. Temple is to install sanitation tools and..

Credit: ANI     Duration: 02:22Published
Day 68 of  #IndiaLockdown: Malls, Hotels, restaurants and places of worship to reopen from June 8th [Video]

Day 68 of #IndiaLockdown: Malls, Hotels, restaurants and places of worship to reopen from June 8th

According to the Union Health Ministry A record single-day jump of 8,380 new patients in the last 24 hours has taken India's coronavirus tally to nearly 1.82 lakh cases. The number of total deaths..

Credit: Oneindia     Duration: 02:16Published
oronavirus: India records single-day jump of 8,380 positive cases in 24-hours| Oneindia News [Video]

oronavirus: India records single-day jump of 8,380 positive cases in 24-hours| Oneindia News

As Indian and Chinese troops remain engaged in a tense border standoff, Defence Minister Rajnath Singh on Saturday asserted that the government will not allow India''s pride to be hurt under any..

Credit: Oneindia     Duration: 02:40Published

Tweets about this